Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
111,111,111
-
Number of holders
-
186
-
Total 13F shares, excl. options
-
65,731,469
-
Shares change
-
+3,744,556
-
Total reported value, excl. options
-
$4,154,391,517
-
Value change
-
+$248,300,371
-
Put/Call ratio
-
33.23%
-
Number of buys
-
112
-
Number of sells
-
-83
-
Price
-
$63.23
Significant Holders of NovoCure Ltd - Common Stock (NVCR) as of Q2 2019
239 filings reported holding NVCR - NovoCure Ltd - Common Stock as of Q2 2019.
NovoCure Ltd - Common Stock (NVCR) has 186 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 65,731,469 shares
of 111,111,111 outstanding shares and own 59.16% of the company stock.
Largest 10 shareholders include FMR LLC (10,303,298 shares), BAILLIE GIFFORD & CO (8,829,449 shares), VANGUARD GROUP INC (6,161,088 shares), BlackRock Inc. (5,554,632 shares), Capital World Investors (5,234,812 shares), PRICE T ROWE ASSOCIATES INC /MD/ (2,357,482 shares), RENAISSANCE TECHNOLOGIES LLC (2,055,470 shares), STATE STREET CORP (1,570,771 shares), Darsana Capital Partners LP (1,500,000 shares), and MACQUARIE GROUP LTD (1,309,220 shares).
This table shows the top 186 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.